Class Action

Grande Enhancement Serums

Class Action

Grande Enhancement Serums


Case Name (Date)

Nixon et al. v. Grande Cosmetics, LLC
22-cv-6639, D.N.J.
(Nov. 2022)


Product/Service

Grande cosmetics, including GrandeLASH-MD Lash Enhancing Serum, GrandeBROW Brow Enhancing Serum, and GrandeHAIR Enhancement Serum


Allegations

Failing to disclose that products contain an active ingredient found in prescription drugs (isopropyl cloprostenate), which may cause serious side effects and which the FDA has only approved for use under the supervision of a doctor


Status

Settled
(Preliminarily approved)

https://gc-settlement.com/



Class-Action Tracker

GrandeLASH-MD, GrandeBROW, and GrandeHAIR Serums

Class Action

GrandeLASH-MD, GrandeBROW, and GrandeHAIR Serums

Allegations: Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow…

Grande Enhancement Serums

Class Action

Grande Enhancement Serums

Allegations: Misleadingly marketing products as safe cosmetics when they are actually drugs that contain an ingredient that poses serious health risks


The Latest

Filters